Details for 2019832954
Up to date per 01.04.2026
Actions
Details for 2019832954
Granted/Registered
European Patent
27.10.2021 A
22.05.2024 B1
21.12.2018
WO
PCT/EP2018/086724
25.01.2019
WO
PCT/EP2019/051830
18.04.2019
WO
PCT/EP2019/060151
21.06.2019
WO
PCT/EP2019/066494
27.06.2019
WO
PCT/EP2019/067186
A61K 31/506 20060101AFI20200701BHEP
Owner
Actelion Pharmaceuticals LtdGewerbestrasse 16 4123 AllschwilCH
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
CSONKA, Dénesc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
FARES, Wassimc/o Janssen Research & Development LLC 920 US Route 202 PO Box 300 Raritan NJ 08869US
HOOGKAMER, Hansc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
TORFS, Koenc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE
Information about Fees